ID   SUIT-4
AC   CVCL_9280
SY   Suit4; SUIzo Tumor-4
DR   cancercelllines; CVCL_9280
DR   Wikidata; Q54970818
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=15452375;
CC   Population: Japanese.
CC   Doubling time: 43.9 hours (PubMed=15452375).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=15452375).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R.,
RA   Saeger H.-D.;
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=15452375; DOI=10.1159/000079500;
RA   Kawano K., Iwamura T., Yamanari H., Seo Y., Suganuma T., Chijiiwa K.;
RT   "Establishment and characterization of a novel human pancreatic cancer
RT   cell line (SUIT-4) metastasizing to lymph nodes and lungs in nude
RT   mice.";
RL   Oncology 66:458-467(2004).
//